The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations
Hungary
315 jobs Number of planned job losses
Announcement Date
4 September 2009
Employment effect (start)
Foreseen end date
7 September 2010
Description
Pharmaceutical company Teva has announced 315 redundancies at its Waterford plant, which manufactures inhalers and tablets. Tablet production will end at the plant within 12 months. Elements of the production of tablets are to be transferred to a plant in Hungary. Currently, approximately 730 workers are employed at the Waterford site.
Sources
4 September 2009: RTE
Citation
Eurofound (2009), Teva, Offshoring/Delocalisation in Ireland, factsheet number 69508, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69508.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
